場調查報告書
]
2014�
之前中東
地�
藥品市場預測：政策環境、市場結構、競爭動向、成長機�
" href="http://06.meetinggoodlookingexposed.com/feed//ar/Files/Personal%20Power/Seduction/djfaq.pdf" />
[市<img src="http://i13.photobucket.com/albums/a279/iMryanmac/suspension/IMG_3001.jpg"/>場調查報告書<img src="http://desadov.com/Clips/SIW1_all.jpg"/>]<img src="http://www.caminomodular.com/i/new/exposed_concrete1Z.jpg"/>2014�<img src="http://www.limousine-orange-county123.com/images/suv140_l.jpg"/>之前中東<img src="http://www.east-of-england.eu/images/meeting.jpg"/>地�<img src="http://www.thevillagenews.com/images/photos/3-22-H&G-Garden%20Club%20meeting%20fox-bat.jpg"/>藥品市場預測：政策環境、市場結構、競爭動向、成長機�<img src="http://noriyaro.com/wp-content/uploads/2009/04/noriyaro_hyper_meeting_april_2009_048.jpg"/>
Good Exposed Meeting Good
[市
場調查報告書]2014�之前中東地�藥品市場預測：政策環境、市場結構、競爭動向、成長機�
06 Meetinggoodlookingexposed Ar Files Personal%20Power Seduction Djfaq Pdf Meeting Good Looking Exposed
Table of Contents
Executive Summary
- The macroeconomic environment in the Middle East
- Healthcare systems in the Middle East
- Pharmaceutical market analysis of the Middle East
- Competitive landscape of the Middle Eastern pharmaceutical market
- Scope and Methodology
- Scope
- Methodology
Chapter 1 The macroeconomic environment in the Middle East
- Summary
- Introduction
- Population profile
- Disease burden
- Macroeconomic comparison of the Middle East
- Economic landscape of key Middle Eastern countries
- Egypt
- Turkey
- Saudi Arabia
- Israel
- Jordan
- UAE
- Lebanon
- Kuwait
Chapter 2 Healthcare systems in the Middle East
- Summary
- Introduction
- Profiles of the healthcare systems across Middle Eastern countries
- Egypt
- Healthcare system
- Intellectual property rights
- Pricing and reimbursement
- Key recent events
- Turkey
- Healthcare system
- Intellectual property rights
- Pricing and reimbursement
- Key recent events
- Saudi Arabia
- Healthcare system
- Intellectual property rights
- Pricing and reimbursement
- Key recent events
- Israel
- Healthcare system
- Intellectual property rights
- Pricing and reimbursement
- Key recent events
- Jordan
- Healthcare system
- Intellectual property rights
- Pricing and reimbursement
- Key recent events
- UAE
- Healthcare system
- Intellectual property rights
- Pricing and reimbursement
- Key recent events
- Lebanon
- Healthcare system
- Intellectual property rights
- Pricing and reimbursement
- Key recent events
- Kuwait
- Healthcare system
- Intellectual property rights
- Pricing and reimbursement
Chapter 3 Pharmaceutical Market analysis in the Middle East
- Summary
- Introduction
- Pharmaceutical market overview
- Therapy area analysis
- Therapy area sales forecast
- Therapy area analysis by country
- Egypt
- Turkey
- Saudi Arabia
- Israel
- Jordan
- UAE
- Lebanon
- Kuwait
- Leading brands analysis
- Seretide (GSK)
- Lipitor (Pfizer)
- Augmentin (GSK/MUP)
- Glivec (Novartis)
- Co-Diovan (Novartis)
- Spiriva (Boehringer Ingelheim)
- Plavix (Sanofi-Aventis)
- Cipralex (Lundbeck)
- Lansor (Sanovel)
- Symbicort (AstraZeneca)
- Leading brands sales forecast
- Key brand analysis by country
- Egypt
- Flumox and Cefotax (Eipico)
- Amaryl (Sanofi-Aventis)
- Cataflam (Novartis)
- Augmentin (MUP)
- Turkey
- Foradil Combi (Novartis)
- Taxotere (Sanofi-Aventis)
- Herceptin (Roche)
- Saudi Arabia
- Augmentin (GSK)
- Snafi (Spimaco)
- Viagra (Pfizer)
- Nexium (AstraZeneca)
- Israel
- Norditropin (Novo Nordisk)
- Seretide (GSK)
- Tritace (Sanofi-Aventis)
- Jordan
- Amoclan (Hikma)
- Similac Gain and Similac Advance (Abbott Nutrition)
- Cerelac (Nestle)
- United Arab Emirates
- Cialis (Eli Lilly)
- Plavix (Sanofi-Aventis)
- Zinnat (GSK)
- Lebanon
- Pariet (J&J)
- Concor (Merck KGaA)
- Crestor (AstraZeneca)
- Kuwait
- Rocephin (Roche)
- Xenical (Roche)
- Yasmin (Bayer)
Chapter 4 Competitive landscape of the Middle Eastern pharmaceutical market
- Summary
- Introduction
- Leading players
- Analysis of key players in the Middle East
- Novartis
- Overview
- Sales focus by leading drug class
- Marketed product portfolio
- Novartis' pipeline focus
- Strategic growth analysis
- GSK
- Overview
- Sales focus by leading drug class
- Marketed product portfolio
- GSK' s pipeline focus
- Strategic growth analysis
- Sanofi-Aventis
- Overview
- Sales focus by leading drug class
- Marketed product portfolio
- Sanofi-Aventis pipeline focus
- Strategic growth analysis
- Pfizer